Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 2

Conditions

Neoplasms 3Febrile Neutropenia 3Neutropenia 2Leukemia 1Hematologic Neoplasms 1Fever 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Cefepime × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed
55 enrolled
Classical hematology

Neoplasms, Febrile Neutropenia

NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Indonesia University

Phase 4 Completed
72 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡